Functional role of high-affinity anandamide transport, as revealed by selective inhibition M Beltramo, N Stella, A Calignano, SY Lin, A Makriyannis, D Piomelli Science 277 (5329), 1094-1097, 1997 | 1087 | 1997 |
Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP H Cadas, S Gaillet, M Beltramo, L Venance, D Piomelli The Journal of neuroscience 16 (12), 3934-3942, 1996 | 426 | 1996 |
Structural determinants for recognition and translocation by the anandamide transporter D Piomelli, M Beltramo, S Glasnapp, SY Lin, A Goutopoulos, XQ Xie, ... Proceedings of the National Academy of Sciences 96 (10), 5802-5807, 1999 | 371 | 1999 |
CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms M Beltramo, N Bernardini, R Bertorelli, M Campanella, E Nicolussi, ... European Journal of Neuroscience 23 (6), 1530-1538, 2006 | 357 | 2006 |
Flow cytometric analysis of inflammatory cells in ischemic rat brain M Campanella, C Sciorati, G Tarozzo, M Beltramo Stroke 33 (2), 586-592, 2002 | 322 | 2002 |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology A Giuffrida, M Beltramo, D Piomelli Journal of Pharmacology and Experimental Therapeutics 298 (1), 7-14, 2001 | 316 | 2001 |
Brain cannabinoids in chocolate E Di Tomaso, M Beltramo, D Piomelli Nature 382 (6593), 677-678, 1996 | 314 | 1996 |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol M Beltramo, D Piomelli Neuroreport 11 (6), 1231-1235, 2000 | 285 | 2000 |
Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor M Beltramo, FR de Fonseca, M Navarro, A Calignano, MA Gorriti, ... The Journal of Neuroscience 20 (9), 3401-3407, 2000 | 281 | 2000 |
Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and … M Rabuffetti, C Sciorati, G Tarozzo, E Clementi, AA Manfredi, M Beltramo The Journal of Neuroscience 20 (12), 4398-4404, 2000 | 257 | 2000 |
Endogenous cannabinoid signaling D Piomelli, M Beltramo, A Giuffrida, N Stella Neurobiology of disease 5 (6), 462-473, 1998 | 215 | 1998 |
Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia‐reperfusion brain injury in the rat G Tarozzo, M Campanella, M Ghiani, A Bulfone, M Beltramo European Journal of Neuroscience 15 (10), 1663-1668, 2002 | 179 | 2002 |
Potentiation of anandamide hypotension by the transport inhibitor, AM404 A Calignano, G La Rana, M Beltramo, A Makriyannis, D Piomelli European journal of pharmacology 337 (1), R1-R2, 1997 | 158 | 1997 |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. A Calignano, G La Rana, A Makriyannis, SY Lin, M Beltramo, D Piomelli European journal of pharmacology 340 (2-3), R7-8, 1997 | 130 | 1997 |
Cannabinoids and neuroprotection RI Grundy, M Rabuffetti, M Beltramo Molecular neurobiology 24 (1-3), 29-51, 2001 | 127 | 2001 |
Fractalkine protein localization and gene expression in mouse brain G Tarozzo, S Bortolazzi, C Crochemore, SC Chen, AS Lira, JS Abrams, ... Journal of neuroscience research 73 (1), 81-88, 2003 | 122 | 2003 |
Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin (ogen) degradation products as trauma-associated markers A Conti, Y Sanchez-Ruiz, A Bachi, L Beretta, E Grandi, M Beltramo, ... Journal of neurotrauma 21 (7), 854-863, 2004 | 118 | 2004 |
Seasonal breeding in mammals: From basic science to applications and back H Dardente, D Lomet, V Robert, C Decourt, M Beltramo, ... Theriogenology 86 (1), 324-332, 2016 | 99 | 2016 |
Cannabinoid type 2 receptor as a target for chronic-pain M Beltramo Mini reviews in medicinal chemistry 9 (1), 11-25, 2009 | 96 | 2009 |
A synthetic kisspeptin analog that triggers ovulation and advances puberty C Decourt, V Robert, K Anger, M Galibert, JB Madinier, X Liu, H Dardente, ... Scientific reports 6, 26908, 2016 | 83 | 2016 |